Intraductal oncocytic papillary neoplasm of the pancreas: A systematic review

• Published in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] Vol. 19; no. 6; pp. 858 - 865
• Main Authors: Wang, Yi-Zhi, Lu, Jun, Jiang, Bo-Lun, Guo, Jun-Chao
• Format: Journal Article
• Language: English
• Published: Switzerland Elsevier B.V 01.09.2019; Elsevier Limited
• Subjects: Abdomen; Age; Antigens; Biomarkers; Biopsy; Carcinoma, Pancreatic Ductal - diagnosis; Carcinoma, Pancreatic Ductal - epidemiology; Carcinoma, Pancreatic Ductal - therapy; Cysts; Diagnosis; Endoscopy; Humans; IOPN-P; IPMN; Lesions; Malignancy; Medical diagnosis; Medical prognosis; Metastases; Metastasis; NMR; Nodules; Nuclear magnetic resonance; Pain; Pancreas; Pancreatic cancer; Pancreatic Neoplasms - diagnosis; Pancreatic Neoplasms - epidemiology; Pancreatic Neoplasms - therapy; Papilloma, Intraductal - diagnosis; Papilloma, Intraductal - epidemiology; Papilloma, Intraductal - therapy; Pathology; Patients; Prognosis; Systematic review; Treatment; Treatment Outcome; Tumors; Ultrasonic imaging; United States > US; IPMN; Prognosis; Treatment; Diagnosis; IOPN-P
• ISSN: 1424-3903; 1424-3911
• DOI: 10.1016/j.pan.2019.07.040

Intraductal oncocytic papillary neoplasm of the pancreas (IOPN–P) is a rare subtype of intraductal papillary mucinous neoplasm (IPMN). This study was performed to summarize the clinicopathological features and management of IOPN-P. English-language articles were searched from MEDLINE and EMBASE from the first report of IOPN-P in 1996 until 1 May 2019 following the methodology in the PRISMA guidelines. In total, 66 patients from 24 full articles were included in the final data analysis. The patients’ average age was 61 years, and the male/female ratio was 1. Most lesions were large (average size, 5.50 cm), located in the pancreatic head, and found either incidentally or by uncharacteristic abdominal symptoms. IOPN-P was usually a cystic and solid lesion with or without mural nodules on radiological examination. A definitive diagnosis was often acquired from fine needle aspiration biopsy or postoperative pathology. All tumors were diagnosed as carcinoma in situ or minimally invasive carcinoma, necessitating surgical resection. The prognosis of IOPN-P was better than that of other IPMN subtypes, even when metastasis occurred. Recurrence after surgical resection of IOPN-P was rare. IOPN-P is rare among IPMN subtypes with unique pathological characteristics. Because of the nontypical symptoms and radiological findings, a definitive preoperative diagnosis usually depends on multimodal examinations. Management and surveillance of IOPN-P after surgical resection should be differentiated from those of other pancreatic benign cystic lesions because of its relative malignancy, but IOPN-P should also be differentiated from other IPMN subtypes and malignant cystic tumors because of its favorable prognosis.